(Q48312866)

10 February 2018

title

Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli. (English)

1 reference

10 February 2018

0 references

McShea A

1

1 reference

10 February 2018

Zelasko DA

series ordinal

2

1 reference

10 February 2018

Gerst JL

series ordinal

3

1 reference

10 February 2018

Smith MA

series ordinal

4

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

10 February 2018

published in

Brain Research

1 reference

10 February 2018

volume

815

1 reference

10 February 2018

page(s)

237-242

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Cell coupling and uncoupling in the ventricular zone of developing neocortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

K-ras modulates the cell cycle via both positive and negative regulatory pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

UV activates growth factor receptors via reactive oxygen intermediates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Diagnosis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Cell cycle markers in the hippocampus in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

NGF and the treatment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Prevention of PC12 cell death by N-acetylcysteine requires activation of the Ras pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Oxidative damage in Alzheimer's.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Widespread peroxynitrite-mediated damage in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Reduced cell-cell communication between mitotic and nonmitotic coupled cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Basic fibroblast growth factor in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Mitotic mechanisms in Alzheimer's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

A neuronal antigen in the brains of Alzheimer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

Induction of basic Fibroblast Growth Factor in Alzheimerʼs disease pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Two waves of cyclin B and proliferating cell nuclear antigen expression during dopamine-triggered neuronal apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901135-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(98)01135-4

1 reference

10 February 2018

PubMed ID

9878757

1 reference

10 February 2018